摘要
靶向药物的设计方法是一系列的计算过程,包括可视化工具,来支持药物设计和发现过程的决策系统。根据生物靶点形成的潜在靶点或药物分子的本质,这篇综述提出了靶向药物设计的不同的组成部分的定位,其中包括目标识别、蛋白建模、分子动力学、捆绑/催化位点识别、对接、虚拟筛选、碎片基础策略、治疗靶点在应对耐药性的子结构、硅易位聚合、结构疫苗学等,及其中所涉及的关键问题和一些案例研究调查。这些概念和工作程序被用钻研眼光进行了讨论,并引起了关注,促进了药物研究。
关键词: 耐药性,同源建模,分子动力学,基于结构的药物设计,结构疫苗学,靶向药物设计,靶点识别,虚拟筛选
Current Medicinal Chemistry
Title:Target Based Drug Design - A Reality in Virtual Sphere
Volume: 22 Issue: 13
Author(s): Saroj Verma and Yenamandra S. Prabhakar
Affiliation:
关键词: 耐药性,同源建模,分子动力学,基于结构的药物设计,结构疫苗学,靶向药物设计,靶点识别,虚拟筛选
摘要: The target based drug design approaches are a series of computational procedures, including visualization tools, to support the decision systems of drug design/discovery process. In the essence of biological targets shaping the potential lead/drug molecules, this review presents a comprehensive position of different components of target based drug design which include target identification, protein modeling, molecular dynamics simulations, binding/catalytic sites identification, docking, virtual screening, fragment based strategies, substructure treatment of targets in tackling drug resistance, in silico ADMET, structural vaccinology, etc along with the key issues involved therein and some well investigated case studies. The concepts and working of these procedures are critically discussed to arouse interest and to advance the drug research.
Export Options
About this article
Cite this article as:
Saroj Verma and Yenamandra S. Prabhakar , Target Based Drug Design - A Reality in Virtual Sphere, Current Medicinal Chemistry 2015; 22 (13) . https://dx.doi.org/10.2174/0929867322666150209151209
DOI https://dx.doi.org/10.2174/0929867322666150209151209 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Approaches to the Treatment of Chronic Inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of miR-129-5p in Cancer: A Novel Therapeutic Target
Current Molecular Pharmacology Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Current Pharmaceutical Design Molecular Link Mechanisms between Inflammation and Cancer
Current Pharmaceutical Design Endothelin-1 and Angiogenesis in Cancer
Current Vascular Pharmacology Targeting Glioblastoma Stem Cells: Cell Surface Markers
Current Medicinal Chemistry Essential Principles and Recent Progress in the Development of TSPO PET Ligands for Neuroinflammation Imaging
Current Medicinal Chemistry A Novel Lily-of-the-Valley Fragrance Contrast Agent for Magnetic Resonance and Fluorescence Imaging of Prostate Cancer Cells
Current Pharmaceutical Biotechnology ABC Transporter Inhibitors in Reversing Multidrug Resistance to Chemotherapy
Current Drug Targets Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis
Current Cancer Drug Targets Cancer Stem Cells and the Biology of Brain Tumors
Current Stem Cell Research & Therapy Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas
Current Pharmaceutical Design Amyloid-Beta Peptide 1-42 Causes Microtubule Deregulation through N-methyl-D-aspartate Receptors in Mature Hippocampal Cultures
Current Alzheimer Research The Potential for Substance P Antagonists as Anti-Cancer Agents in Brain Tumours
Recent Patents on CNS Drug Discovery (Discontinued) Cellular Photodynamic Toxicity of Hematoporphyrin in Various Nanocarrier Systems
Current Nanoscience Cancer Treatment with Liposomes Based Drugs and Genes Co-delivery Systems
Current Medicinal Chemistry PPARγ and Early Human Placental Development
Current Medicinal Chemistry Heterocyclic Amaryllidaceae Alkaloids: Biosynthesis and Pharmacological Applications
Current Topics in Medicinal Chemistry Medicinal Plants for Glioblastoma Treatment
Anti-Cancer Agents in Medicinal Chemistry The Use of Immortalized Cell Lines in GPCR Screening: The Good, Bad and Ugly.
Combinatorial Chemistry & High Throughput Screening